MARKER THERAPEUTICS, INC. Shareholders' Equity
MARKER THERAPEUTICS, INC. (MRKR) had Shareholders' Equity of $12.17 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $12.17M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $13.80M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $16.80M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $18.39M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $12.17M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $13.80M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $16.80M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $18.39M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $10.49M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $14.49M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $18.56M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $7.45M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $9.70M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $11.79M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $14.05M 10-K · filed 2026-03-18 | |
| 2023-09-30 | $16.71M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $19.03M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $15.91M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $19.60M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $22.60M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $28.03M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $35.71M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $43.99M 10-K · filed 2024-03-26 | |
| 2021-09-30 | $52.28M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $63.24M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $72.49M 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $27.34M 10-K · filed 2023-03-22 | |
| 2020-09-30 | $30.60M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $34.51M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $39.50M 10-Q · filed 2021-08-10 | |
| 2019-12-31 | $44.09M 10-K · filed 2022-03-17 | |
| 2019-09-30 | $47.88M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $51.40M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $55.61M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $59.34M 10-K · filed 2021-03-09 | |
| 2018-09-30 | $690.47K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $4.14M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $615.96K 10-Q · filed 2019-08-09 | |
| 2017-12-31 | $3.66M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $5.94M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $8.57M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $4.14M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $6.18M 10-K · filed 2019-03-15 | |
| 2016-09-30 | $7.49M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | -$19.33M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$25.70M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$21.36M 10-K · filed 2018-03-23 | |
| 2015-09-30 | -$27.39M 10-Q/A · filed 2016-04-14 | -$2.62M 10-Q · filed 2015-11-16 |
| 2015-06-30 | -$68.10M 10-Q/A · filed 2016-04-14 | -$9.81M 10-Q · filed 2015-08-14 |
| 2015-03-31 | -$8.71M 10-Q/A · filed 2016-04-14 | -$1.77M 10-Q · filed 2015-05-15 |
| 2014-12-31 | -$1.02M 10-K · filed 2017-03-14 | |
| 2014-09-30 | -$656.20K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | -$2.56M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | -$5.51M 10-Q/A · filed 2014-05-21 | |
| 2013-12-31 | -$8.77M 10-K · filed 2016-04-14 | |
| 2013-09-30 | -$5.10M 10-Q · filed 2013-11-19 | |
| 2013-03-31 | -$5.49M 10-Q/A · filed 2013-08-19 | |
| 2012-12-31 | -$6.04M 10-K · filed 2015-04-15 | -$5.67M 10-K · filed 2013-05-15 |
| 2012-09-30 | -$4.37M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | -$3.70M 10-Q/A · filed 2012-09-12 | |
| 2012-03-31 | -$3.61M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | -$3.46M 10-K · filed 2013-05-15 | |
| 2011-09-30 | -$2.18M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | -$1.78M 10-Q · filed 2011-08-22 | |
| 2010-12-31 | -$3.87M 10-K · filed 2012-04-16 | -$3.27M 10-Q · filed 2011-08-22 |
| 2009-12-31 | -$1.78M 10-K · filed 2012-04-16 | |
| 2008-12-31 | -$3.02M 10-K · filed 2012-04-16 | |
| 2007-12-31 | -$1.67M 10-K · filed 2012-04-16 | |
| 2006-12-31 | -$3.00M 10-K · filed 2012-04-16 | |
| 2005-12-31 | -$2.22M 10-K · filed 2012-04-16 | |
| 2004-12-31 | -$2.44M 10-K · filed 2012-04-16 | |
| 2003-12-31 | -$643.75K 10-K · filed 2012-04-16 | |
| 2002-12-31 | $465.83K 10-K · filed 2012-04-16 | |
| 2001-12-31 | -$74.05K 10-K · filed 2012-04-16 | |
| 2000-12-31 | $252.23K 10-K · filed 2012-04-16 | |
| 1999-12-31 | $100.37K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |